Incyte (INCY) News Today $68.59 -1.75 (-2.49%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$68.33 -0.26 (-0.37%) As of 07/11/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INCY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period DekaBank Deutsche Girozentrale Trims Stock Holdings in Incyte Corporation (NASDAQ:INCY)July 12 at 4:59 AM | marketbeat.comBank of New York Mellon Corp Raises Stake in Incyte Corporation (NASDAQ:INCY)July 11 at 4:27 AM | marketbeat.comIncyte’s Q2 2025 Earnings: What to ExpectJuly 10 at 12:55 PM | finance.yahoo.comIncyte to Report Second Quarter Financial ResultsJuly 10 at 9:05 AM | gurufocus.comLbp Am Sa Sells 7,738 Shares of Incyte Corporation (NASDAQ:INCY)July 10 at 7:08 AM | marketbeat.comTeacher Retirement System of Texas Has $2.71 Million Stake in Incyte Corporation (NASDAQ:INCY)July 10 at 3:49 AM | marketbeat.comWilliam Blair Maintains ‘Hold’ Rating on Incyte Corporation (INCY), Citing Future Revenue UncertaintiesJuly 9, 2025 | msn.comVijay K. Iyengar Sells 8,617 Shares of Incyte Corporation (NASDAQ:INCY) StockJuly 9, 2025 | americanbankingnews.comBarry P. Flannelly Sells 10,903 Shares of Incyte Corporation (NASDAQ:INCY) StockJuly 8, 2025 | americanbankingnews.comIFM Investors Pty Ltd Has $2.43 Million Stake in Incyte Corporation (NASDAQ:INCY)July 8, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) EVP Sells $41,097.39 in StockJuly 8, 2025 | insidertrades.comInsider Selling: Incyte Corporation (NASDAQ:INCY) EVP Sells 599 Shares of StockJuly 7, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) EVP Vijay K. Iyengar Sells 8,617 SharesJuly 7, 2025 | marketbeat.comInsider Selling: Incyte Corporation (NASDAQ:INCY) EVP Sells 10,903 Shares of StockJuly 7, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Trims Stock Position in Incyte Corporation (NASDAQ:INCY)July 7, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) Given Consensus Rating of "Hold" by BrokeragesJuly 7, 2025 | americanbankingnews.comIncyte Corporation (NASDAQ:INCY) Receives Consensus Rating of "Hold" from AnalystsJuly 7, 2025 | marketbeat.comNew York State Teachers Retirement System Sells 7,383 Shares of Incyte Corporation (NASDAQ:INCY)July 4, 2025 | marketbeat.comIncyte’s Phase 1 Study on INCB057643: A Potential Game-Changer for Myelofibrosis Treatment?July 3, 2025 | tipranks.comIncyte’s Phase 2 Study on INCB099280: A Potential Breakthrough in Skin Cancer TreatmentJuly 3, 2025 | tipranks.comIncyte’s Phase 3 Study Update: Potential Market Impact for HNSCC TreatmentJuly 3, 2025 | tipranks.comIncyte: New CEO Brings A New Possible OutcomeJuly 3, 2025 | seekingalpha.comIncyte’s Future Hinges on Pipeline Potential Amid Jakafi Exclusivity LossJuly 3, 2025 | tipranks.comSumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)July 3, 2025 | marketbeat.comIncyte Corp (INCY) Announces Equity Inducement Awards for New CEO Bill Meury | INCY stock newsJuly 2, 2025 | gurufocus.comIncyte’s Promising Phase 1/2 Study: A New Hope for Advanced Solid TumorsJuly 2, 2025 | tipranks.comNotable Insider Move: William Meury Takes Part In Options Exercise At Incyte, Resulting In $0July 2, 2025 | benzinga.comIncyte’s Phase 1 Study on INCB057643: A Potential Game-Changer in Myelofibrosis Treatment?July 1, 2025 | tipranks.comCHURCHILL MANAGEMENT Corp Increases Stock Holdings in Incyte Corporation (NASDAQ:INCY)July 1, 2025 | marketbeat.comBessemer Group Inc. Sells 32,765 Shares of Incyte Corporation (NASDAQ:INCY)July 1, 2025 | marketbeat.comIncyte’s Ongoing Rollover Study of Povorcitinib: Key Insights for InvestorsJune 30, 2025 | tipranks.comJim Cramer Highlights That Incyte’s New CEO is an “Industry Veteran”June 30, 2025 | insidermonkey.comJim Cramer Highlights That Incyte’s New CEO is an “Industry Veteran”June 30, 2025 | finance.yahoo.comKBC Group NV Reduces Stock Position in Incyte Corporation (NASDAQ:INCY)June 30, 2025 | marketbeat.com23,678 Shares in Incyte Corporation (NASDAQ:INCY) Acquired by Sovran Advisors LLCJune 30, 2025 | marketbeat.comIllinois Municipal Retirement Fund Reduces Holdings in Incyte Corporation (NASDAQ:INCY)June 28, 2025 | marketbeat.comDiversified Trust Co Sells 6,555 Shares of Incyte Corporation (NASDAQ:INCY)June 28, 2025 | marketbeat.comIncyte's New CEO Is A Dealmaking Machine. Will He Bring That Fervor To His New Role?June 27, 2025 | investors.comIncyte’s Phase 3 Study on Povorcitinib: A Potential Game-Changer for Prurigo NodularisJune 27, 2025 | tipranks.comIncyte’s Phase 3 Study on Axatilimab: A Potential Game-Changer for cGVHD TreatmentJune 27, 2025 | tipranks.comIncyte’s New Study on INCB177054: A Potential Game-Changer in Cancer Treatment?June 27, 2025 | tipranks.comIncyte’s Challenges and Potential Amid Leadership Change and R&D HurdlesJune 27, 2025 | tipranks.comIncyte Corporation (NASDAQ:INCY) Shares Acquired by Robeco Institutional Asset Management B.V.June 27, 2025 | marketbeat.comIncyte stock rises as William Blair reiterates market perform ratingJune 26, 2025 | investing.comIncyte’s Leadership Transition and Pipeline Uncertainty Justify Hold RatingJune 26, 2025 | tipranks.comIncyte stock rises after appointing Bill Meury as new CEOJune 26, 2025 | investing.comIncyte Stock Rises as Pharmaceutical Firm Appoints New CEOJune 26, 2025 | msn.comIncyte (NASDAQ:INCY) Shares Gap Up - Time to Buy?June 26, 2025 | marketbeat.comWhy New Incyte CEO Bill Meury Is Stoking Investors' M&A HopesJune 26, 2025 | investors.comIncyte taps Bill Meury as CEOJune 26, 2025 | seekingalpha.com Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address INCY Media Mentions By Week INCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼0.740.99▲Average Medical News Sentiment INCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼2118▲INCY Articles Average Week Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AbbVie News Today Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Neurocrine Biosciences News Today Exelixis News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Repligen News Today Halozyme Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Incyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
